Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole ointment regimens in Japanese patients with mild to moderate atopic dermatitis
2020-000875-20Phase 2
- Sponsor
- Pfizer
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of crisaborole in atopic dermatitis (AD) (2 arms), sponsored by Pfizer. Primary endpoint: Change from baseline in Total Sign Score on Day 15.
02
Drugs
crisaborole
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2020-000875-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000875-20.